Here’s what you should know:
1. The capsules are proton pump inhibitors used to treat gastroesophageal reflux disease. They also reduce the risk of duodenal ulcer nonsteroidal anti-inflammatory drug-associated gastric ulcers.
2. The product can be marketed to gastroenterologists in select U.S. areas.
3. Redhill believes promotion will begin in the next few weeks.
4. This is RedHill’s third U.S.-based product.
More articles on gastroenterology:
GI center to know: Gateway Gastroenterology
United Healthcare honors Dr. Darrien Gaston of Metropolitan Gastroenterology Consultants — 3 key notes
Providence Medical Group adds a new physician & more: 4 GI practices in the news
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
